TIDMODX

RNS Number : 2811B

Omega Diagnostics Group PLC

06 June 2019

Omega Diagnostics Group PLC

("Omega" or "the Company" or the "Group")

Announcement of Results

Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that it will release its results for the year ended 31 March 2019 on Monday 19 August 2019.

Contacts:

 
  Omega Diagnostics Group PLC                                 Tel: 01259 763 030 
 Bill Rhodes, Interim Non-Executive                     www.omegadiagnostics.com 
  Chairman 
  Colin King, Chief Executive 
 Kieron Harbinson, Group Finance 
  Director 
 
 finnCap Ltd                                                  Tel: 020 7220 0500 
 Geoff Nash/James Thompson/ Hannah 
  Boros (Corporate Finance) 
 Camille Gochez (ECM) 
 
 Walbrook PR Limited                  Tel: 020 7933 8780 or omega@walbrookpr.com 
 Paul McManus                                                 Mob: 07980 541 893 
 Lianne Cawthorne                                             Mob: 07584 391 303

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

NORSSEFIIFUSEDM

(END) Dow Jones Newswires

June 06, 2019 02:01 ET (06:01 GMT)

Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Omega Diagnostics Charts.
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Omega Diagnostics Charts.